GB2618145A — Manifold
Assigned to Merxin Ltd · Expires 2023-11-01 · 3y expired
What this patent protects
A manifold 100 for delivery of medicament powder from a dispenser device 10 comprising a first chamber directing a first flow of air 110 from an inlet 102A to an outlet 102B, a conduit 104 with inlet 104A and outlet 104B, the first chamber outlet and conduit inlet arranged such t…
USPTO Abstract
A manifold 100 for delivery of medicament powder from a dispenser device 10 comprising a first chamber directing a first flow of air 110 from an inlet 102A to an outlet 102B, a conduit 104 with inlet 104A and outlet 104B, the first chamber outlet and conduit inlet arranged such that the first flow of air passes from the first chamber to the conduit via a medicament powder from a source such as a blister pack, entraining it and providing a flow of air and powder through the conduit. A bleed inlet 106 is located in a wall of the conduit outside of the first chamber and arranged to direct a second flow of air 112 into the conduit to disrupt the flow of air and powder through the conduit. The bleed inlet may be the outlet of a second chamber 108. The conduit may connect to a mouthpiece 19.
Drugs covered by this patent
- Arnuity Ellipta (FLUTICASONE FUROATE) · Haleon Us Holdings
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.